Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
bifidobacterium breve (2 trials)
bifidobacterium infantis (2 trials)
bifidobacterium longum (2 trials)
doxycycline (vibramycin) (1 trial)
Lactobacillus acidophilus (2 trials)
lactobacillus brevis (4 trials)
lactobacillus casei (2 trials)
lactobacillus delbrueckii (2 trials)
lactobacillus plantarum (2 trials)
lactulose (cephulac) (1 trial)
streptococcus salivarius (2 trials)
vsl #3 (2 trials)
Brain Diseases (Phase 3)
Chronic Periodontitis (Phase 3)
Gingivitis (Phase 3)
Hepatic Encephalopathy (Phase 3)
Liver Diseases (Phase 3)
Periodontitis (Phase 3)
Trials (6 total)
Trial APIs (12 total)